Table 1.
Group | Treatment | No./cm2 | mm2/cm2 | mm2/No. |
A | Normal control | 167.29 ± 50.47 | 2.90 ± 1.01 | 0.017 ± 0.002 |
B | AFB1 | 71.92 ± 42.19a | 1.14 ± 0.69a | 0.015 ± 0.002 |
C | AFB1 + OLT daily | 167.10 ± 45.94cd | 2.73 ± 0.87cd | 0.016 ± 0.001 |
D | AFB1 + OLT weekly | 83.66 ± 34.94a | 1.33 ± 0.86a | 0.015 ± 0.002b |
t test:
P < 0.05,
P < 0.01, vs group A;
P < 0.01, vs group B;
P < 0.01, vs group D. OLT: Oltipraz; No./cm2: The number of γ-GT positive hepatocyte-group per cm2 of liver tissue; mm2/cm2: mm2 of γ-GT positive hepatocyte-group per cm2 of liver tissue; mm2/No.: mm2 of γ-GT positive hepatocyte-group per each one.